Skip to main content

Search Videos and More

Showing 97 - 108 of 108 results

Previous| 1... 5 | 6 | 7 |Next

The Adjuvant Use of Immunotherapy for Bladder Cancer

The Adjuvant Use of Immunotherapy for Bladder Cancer

Bladder Cancer Treatment Without Cystectomy

Bladder Cancer Treatment Without Cystectomy

Genomics and Prostate Cancer

Genomics and Prostate Cancer

NIH Awards Mount Sinai Researchers $12 Million to Personalize Sickle Cell Treatment

NIH Awards Mount Sinai Researchers $12 Million to Personalize Sickle Cell Treatment

Joseph Sparano, MD, leads Hematology and Medical Oncology and is Deputy Director of The Tisch Cancer Institute

Joseph Sparano, MD, leads Hematology and Medical Oncology and is Deputy Director of The Tisch Cancer Institute

Genomic Landscape of Lung Adenocarcinoma

Genomic Landscape of Lung Adenocarcinoma

A Promising Strategy for Preventing Cancer Metastasis and Enhancing Dormancy

A Promising Strategy for Preventing Cancer Metastasis and Enhancing Dormancy

An Engineered Molecule, MS21, Slows the Growth of Multiple Tumor Types

An Engineered Molecule, MS21, Slows the Growth of Multiple Tumor Types

The Tisch Cancer Institute Specialty Report 2023

The Tisch Cancer Institute Specialty Report 2023

Cancer Immunotherapy: In Search of the Other “C” Word (Cure) for Cancer Patients

Cancer Immunotherapy: In Search of the Other “C” Word (Cure) for Cancer Patients

Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA

Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA

Pulmonary Hypertension

Pulmonary Hypertension

Showing 97 - 108 of 108 results

Previous| 1... 5 | 6 | 7 |Next